Jeanne M Ferrante1,2,3, Aaron Lulla4, Julie D Williamson4, Katie A Devine2, Pamela Ohman-Strickland2,5, Elisa V Bandera2. 1. Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. 2. Cancer Prevention, Control, and Population Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. 3. Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ, USA. 4. Preliminary Medicine, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA. 5. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.
Abstract
PURPOSE: This study examined adherence with a physical activity tracker and patterns of activity among different subgroups of African American/Black breast cancer survivors (AABCS). DESIGN: Secondary analysis of weight loss trial that used an activity tracker (FitBit) with or without a commercial eHealth program (SparkPeople) over 12 months. SETTING AND SUBJECTS: AABCS (N = 44) in New Jersey. MEASURES AND ANALYSIS: Adherence with tracker use, steps per day, and active minutes per week were compared by demographic and clinical characteristics using nonparametric statistics. RESULTS: Median adherence was over 6 days per week throughout the 12-months. Adherence was significantly correlated with steps and active minutes (p < 0.015). Groups with lower adherence included: those with 5 or more conditions (p = 0.039), had higher number of household members (p = 0.008), and younger than 60 years (p = 0.044). Median number of steps per day remained consistently around 7000 throughout 12 months. Factors associated with lower activity included: age > 60; retirement; higher number of household members, comorbidity, or baseline BMI; and those in the SparkPeople + Fitbit group. Self-monitoring, goal setting, and self-efficacy were significantly correlated with activity levels (p < 0.05). CONCLUSION: Use of a physical activity tracker may help increase activity levels in AABCS. Certain subgroups, e.g. those older than age 60 years, retired, with BMI over 40, higher number of comorbidities or more household members, may require additional interventions.
PURPOSE: This study examined adherence with a physical activity tracker and patterns of activity among different subgroups of African American/Black breast cancer survivors (AABCS). DESIGN: Secondary analysis of weight loss trial that used an activity tracker (FitBit) with or without a commercial eHealth program (SparkPeople) over 12 months. SETTING AND SUBJECTS: AABCS (N = 44) in New Jersey. MEASURES AND ANALYSIS: Adherence with tracker use, steps per day, and active minutes per week were compared by demographic and clinical characteristics using nonparametric statistics. RESULTS: Median adherence was over 6 days per week throughout the 12-months. Adherence was significantly correlated with steps and active minutes (p < 0.015). Groups with lower adherence included: those with 5 or more conditions (p = 0.039), had higher number of household members (p = 0.008), and younger than 60 years (p = 0.044). Median number of steps per day remained consistently around 7000 throughout 12 months. Factors associated with lower activity included: age > 60; retirement; higher number of household members, comorbidity, or baseline BMI; and those in the SparkPeople + Fitbit group. Self-monitoring, goal setting, and self-efficacy were significantly correlated with activity levels (p < 0.05). CONCLUSION: Use of a physical activity tracker may help increase activity levels in AABCS. Certain subgroups, e.g. those older than age 60 years, retired, with BMI over 40, higher number of comorbidities or more household members, may require additional interventions.
Entities:
Keywords:
African American; activity trackers; breast cancer survivors; physical activity
Authors: Jeanne M Ferrante; Katie A Devine; Alicja Bator; Ashley Rodgers; Pamela A Ohman-Strickland; Elisa V Bandera; Kevin O Hwang Journal: Transl Behav Med Date: 2020-10-08 Impact factor: 3.046
Authors: Frederico Soares Falcetta; Henrique de Araújo Vianna Träsel; Fernando Kude de Almeida; Mariana Rangel Ribeiro Falcetta; Maicon Falavigna; Daniela Dornelles Rosa Journal: Breast Cancer Res Treat Date: 2018-04-13 Impact factor: 4.872
Authors: S C Hayes; M L Steele; R R Spence; L Gordon; D Battistutta; J Bashford; C Pyke; C Saunders; E Eakin Journal: Breast Cancer Res Treat Date: 2017-10-23 Impact factor: 4.872
Authors: Sheri J Hartman; Sandahl H Nelson; Emily Myers; Loki Natarajan; Dorothy D Sears; Barton W Palmer; Lauren S Weiner; Barbara A Parker; Ruth E Patterson Journal: Cancer Date: 2017-09-19 Impact factor: 6.860
Authors: Clement G Yedjou; Jennifer N Sims; Lucio Miele; Felicite Noubissi; Leroy Lowe; Duber D Fonseca; Richard A Alo; Marinelle Payton; Paul B Tchounwou Journal: Adv Exp Med Biol Date: 2019 Impact factor: 2.622
Authors: Elisa V Bandera; Urmila Chandran; Gary Zirpoli; Zhihong Gong; Susan E McCann; Chi-Chen Hong; Gregory Ciupak; Karen Pawlish; Christine B Ambrosone Journal: BMC Cancer Date: 2013-10-14 Impact factor: 4.430